Diabetic patients showed significant Substance P and inflammatory marker increases in the unoperated eye after first-eye cataract surgery.
51 patientsshowed that diabetic patients had significantly higher cross-eye inflammation after cataract surgery
What the researchers found
In diabetic patients, Substance P (SP) and MCP-1 levels both rose significantly in the contralateral (opposite) eye after the first cataract surgery, whether the second surgery was 1 day or 1 week later (P ≤ 0.040). The SP increase in diabetic patients was significantly higher than in non-diabetic patients (P ≤ 0.030) at both time intervals.
MCP-1, a protein that attracts immune cells, also increased more in diabetic patients, reaching statistical significance in the 1-week interval group (P = 0.042).
This suggests that surgery on one eye triggers a sympathetic inflammatory response in the other eye, and diabetes amplifies this response. This may explain why diabetic patients often report more pain during their second eye surgery.
Why it matters
Cataract surgery is one of the most common surgeries worldwide. Many patients need both eyes done. This study reveals that diabetic patients mount an inflammatory response in the unoperated eye, driven by Substance P. Understanding this mechanism could lead to better pain management and timing strategies for sequential cataract surgeries in diabetic patients.
The numbers in context
51 patients; SP increase P≤0.030 diabetic vs non-diabetic; MCP-1 increase P=0.042 at 1-week interval
How the study worked
A prospective randomized clinical study with 51 cataract patients: 22 with type 2 diabetes and 29 without. Patients were randomized to have their second eye surgery at either 1-day or 1-week intervals. Aqueous humor (eye fluid) samples of more than 100 microliters were collected before each surgery. Researchers measured 10 inflammatory markers plus Substance P using Luminex assays and ELISA.
Who was studied
51 cataract patients (22 with type 2 diabetes, 29 without)
What this study cannot tell us
The sample size of 51 patients is modest, especially when split into four subgroups (diabetic/non-diabetic crossed with 1-day/1-week). The study only measured two time intervals, so the full time course of the inflammatory response is unknown. The mechanism connecting surgery on one eye to SP release in the other was not directly tested.
How to read the evidence
Moderate evidence from a prospective randomized clinical study. Small but well-designed, with clear statistical significance for the key findings.
When this study was published
Published in 2020. This finding has implications for surgical planning that may already be influencing clinical practice.
The bigger picture
Cataract surgery is one of the most common surgeries worldwide. Understanding that diabetic patients mount a cross-eye inflammatory response could change how surgeons time bilateral procedures and manage postoperative inflammation in this large patient population.
Questions still open
- Would anti-Substance P treatments before the second surgery reduce pain and inflammation?
- Is there an optimal waiting period between eyes that minimizes the inflammatory response?
- Do other neuropeptides contribute to this cross-eye effect?
Common questions
Why does cataract surgery in one eye affect the other eye?
Should diabetic patients wait longer between cataract surgeries?
Read the original research
Substance P induces sympathetic immune response in the contralateral eye after the first eye cataract surgery in type 2 diabetic patients.
BMC ophthalmology, 20(1), 339
Citation
Gong, Xianhui; Ren, Yueping; Fang, Xiuxiu; Cai, Junyong; Song, E. (2020). Substance P induces sympathetic immune response in the contralateral eye after the first eye cataract surgery in type 2 diabetic patients.. BMC ophthalmology, 20(1), 339. https://doi.org/10.1186/s12886-020-01598-4